Home Premarket Biotech Digest: Gilead's Upside, Shire-Baxalta Deal, ARIAD Lowers Guidance
 

Keywords :   


Premarket Biotech Digest: Gilead's Upside, Shire-Baxalta Deal, ARIAD Lowers Guidance

2015-12-14 14:57:58| Biotech - Topix.net

I will be looking at some of the big names in the biotech sector over the next two weeks, starting with Gilead Sciences today. Within the large cap growth space in the biotech sector , Gilead continues to be my top pick.

Tags: deal guidance digest biotech

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
20.05Eastern North Pacific Tropical Weather Outlook
20.05Atlantic Tropical Weather Outlook
20.05Water investors have withdrawn billions, says research
19.05Atlantic Tropical Weather Outlook
19.05Eastern North Pacific Tropical Weather Outlook
19.05IT Cosmetics and Kenvue Launch New Products
19.05Virgin Trains targets West Coast in return to rail
19.05Cashing In On The Stache
More »